Tag: Vaccines
Pfizer COVID-19 Vaccines 73 Percent Protective in Under 5s
Specially formulated doses for America's youngest children were approved for distribution in June
COVID-19 Vaccination Does Not Negatively Impact Fertility
Findings seen for women undergoing in vitro fertilization-fresh embryo transfer cycle
HPV Vaccination, Infection Rates Examined in U.S. Women
Reduction in HPV-16/18 infection prevalence seen among a recent birth cohort of vaccinated and unvaccinated 18- to 26-year-old women
Adenoviral-Based COVID-19 Vaccines May Up Short-Term CV Risk
Increased incidence of myocardial infarction, pulmonary embolism seen in second week after first dose of Oxford-AstraZeneca vaccine
For Many, Myocarditis Risk Higher After SARS-CoV-2 Infection Than Vaccination
But myocarditis risk higher after vaccination for men younger than age 40 years, particularly after second dose of mRNA-1273
Pfizer Asks FDA to Approve Omicron-Specific Booster Shot
Animal studies show that the new mRNA vaccine produces an immune response against both BA.4 and BA.5 subvariants
Nurse-Led Interventions May Cut Children’s Fear of Needles
Divided attention and positive memory reframing are feasible and may reduce vaccine-related distress
Universal Health Care Affects Childhood Vaccination Rates
Countries with greater progress toward UHC had smaller declines in childhood immunization coverage during COVID-19 pandemic
Multidose BCG Protects Against COVID-19 in At-Risk Individuals
Efficacy of 92 percent found among at-risk COVID-19-unvaccinated individuals with type 1 diabetes
COVID-19 Risk for Dialysis Patients Tied to Antibody Response to Vaccine
During omicron, risk for SARS-CoV-2 infection dependent on antibody response to COVID-19 vaccine regardless of number of doses
